
Probability of target attainment analyses for dose selection in antimicrobial drug development
more
COVID-19 and why tackling the silent crisis of drug-resistant infections matters more than ever – by Manica Balasegaram
more
PK/PD murine infection models: Focus on study elements, variability, and interpretation of results
more
Bringing antimicrobial research and development to Africa – the time is now – by Greg Basarab and Kelly Chibale
more
Are new antibiotic combinations the solution to the AMR crisis? – by Anthony Coates
more
Ramesh Agarwal
Professor of Paediatrics
All India Institute of Medical Sciences
more

M. Javad Aman
President
Integrated BioTherapeutics, Inc.
more

Jeffrey Ambroso
Toxicologist
RTI International
more

Anand Anandkumar
Co-founder and CEO
Bugworks
more

Antoine Andremont
Emeritus Professor
Paris Diderot University Medical School
more